Wells Fargo & Company CORBUS PHARMACEUTICALS HLDGS Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
251
Previous 6,648 96.22%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-6,397 Reduced 96.22%
251 $0
Q1 2025

May 13, 2025
BUY
N/A
204 Added 3.17%
6,648 $0
Q4 2024

Feb 12, 2025
BUY
N/A
2,195 Added 51.66%
6,444 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-384 Reduced 8.29%
4,249 $0
Q2 2024

Aug 13, 2024
BUY
N/A
3,552 Added 328.58%
4,633 $0
Q1 2024

May 10, 2024
BUY
N/A
1,047 Added 3079.41%
1,081 $0
Q4 2023

Feb 09, 2024
SELL
N/A
-581 Reduced 94.47%
34 $0
Q3 2023

Nov 13, 2023
BUY
N/A
535 Added 668.75%
615 $0
Q2 2023

Aug 15, 2023
BUY
N/A
1 Added 1.27%
80 $0
Q1 2023

May 12, 2023
BUY
N/A
79 New
79 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email